K. Owen

发表

Low Density Lipoprotein Receptor-related Protein 1 (LRP1)-mediated Endocytic Clearance of a Disintegrin and Metalloproteinase with Thrombospondin Motifs-4 (ADAMTS-4)

A. Parker, D. Strickland, S. D. Scilabra, 2014, The Journal of Biological Chemistry.

expressing the type-II transmembrane serine protease matriptase Initiation of plasminogen activation on the surface of monocytes

A. Bar-Or, V. Ellis, R. Bass, 2011 .

Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase.

A. Bar-Or, V. Ellis, R. Bass, 2006, Blood.

A multidrug efflux phenotype mutant of Streptococcus pyogenes.

M. Gill, N. Brenwald, K. Owen, 2003, The Journal of antimicrobial chemotherapy.

Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment.

R. Waring, R. M. Harris, R H Waring, 2004, The Journal of clinical endocrinology and metabolism.

Processing of tumour necrosis factor-α precursor by metalloproteinases

A. H. Drummond, L. Wood, J. Clements, 1994, Nature.

Roles and regulation of membrane-associated serine proteases.

K. Gray, V. Ellis, R. Bass, 2007, Biochemical Society transactions.

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

R. F. Johnston, Robert W. Taylor, Steven C. Johnson, 1994 .

Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.

Jennifer L. Harris, V. Ellis, J. Alves, 2010, The Biochemical journal.

Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II

Edward W. Tate, V. Ellis, T. Bugge, 2014, Thrombosis and Haemostasis.